ClinicalTrialsFinder
RecruitingNot ApplicableNCT06902168

Effect of Diving and Aquatic Exercises on Muscle Spasticity and Motor Function in Children With Spastic Cerebral Palsy

Sponsor

Benha University

Enrollment

37 participants

Start Date

Mar 29, 2025

Study Type

INTERVENTIONAL

Conditions

Spastic Cerebral PalsyMuscle SpasticityMotor FunctionChildrenDivingAquatic

Summary

This study aims to evaluate the effect of diving and aquatic exercises on muscle spasticity and motor function in children with spastic cerebral palsy.

Eligibility

Min Age: 2 YearsMax Age: 5 Years

Inclusion Criteria3

  • Age from 2 to 5 years.
  • Both sexes.
  • Children diagnosed with spastic cerebral palsy, categorized according to the Gross motor function classification system (GMFCS) levels IV, V.

Exclusion Criteria3

  • Botulinum toxin treatment or surgery in the preceding three months.
  • Botox injections before or during the application of the program.
  • Dorsal rhizotomy.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERIntensive swimming program

The participants will be enrolled in an intensive swimming program for 8 weeks (45 minutes) in the swimming pool. The swimming program will be to improve safety and functional independence in the water. The hydrotherapy will be performed at a swimming pool temperature suitable for the weather temperature.

Locations(1)

Benha University (faculty of physical education)

Banhā, Benha, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06902168

Related Trials

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

NCT05457283178 locations

A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults

NCT067614171 location

Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors

NCT069267511 location

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients

NCT070438941 location

Comparing Game-Based Reward Systems to Support Children's Engagement:

NCT075094891 location